In 2007, the international working group (IWG) published the first research criteria for the diagnosis of prodromal AD, which allowed for the use of biomarkers like CSF Aβ42, tau, volumetric MRI, and amyloid PET [12]. Here, MAPT is linked to Alzheimer disease.